DNTH logo

Dianthus Therapeutics, Inc. (DNTH) Return On Equity

Annual ROE:

-32.60%+3.32%(+9.24%)
December 31, 2024

Summary

  • As of today (October 5, 2025), DNTH annual return on equity is -32.60%, with the most recent change of +3.32% (+9.24%) on December 31, 2024.
  • During the last 3 years, DNTH annual ROE has risen by +12.34% (+27.46%).
  • DNTH annual ROE is now -41.00% below its all-time high of -23.12%, reached on December 31, 2022.

Performance

DNTH ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHprofitability metrics

Quarterly ROE:

-34.15%-5.37%(-18.66%)
June 30, 2025

Summary

  • As of today (October 5, 2025), DNTH quarterly return on equity is -34.15%, with the most recent change of -5.37% (-18.66%) on June 30, 2025.
  • Over the past year, DNTH quarterly ROE has dropped by -9.57% (-38.93%).
  • DNTH quarterly ROE is now -44.15% below its all-time high of -23.69%, reached on September 30, 2024.

Performance

DNTH Quarterly ROE Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherDNTHprofitability metrics

ROE Formula

ROE =  Net Income
Shareholders Equity
✕ 100%

DNTH ROE Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1Y1 Year+9.2%-38.9%
3Y3 Years+27.5%+24.4%
5Y5 Years+39.1%+35.9%

DNTH ROE Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs Low
3Y3-Year-41.0%+27.5%-44.1%+22.8%
5Y5-Year-41.0%+39.1%-44.1%+35.1%
All-TimeAll-Time-41.0%+72.7%-44.1%+59.0%

DNTH ROE History

DateAnnualQuarterly
Jun 2025
-
-34.15%(+18.7%)
Mar 2025
-
-28.78%(+7.7%)
Dec 2024
-32.60%(-9.2%)
-26.72%(+12.8%)
Sep 2024
-
-23.69%(-3.6%)
Jun 2024
-
-24.58%(-14.6%)
Mar 2024
-
-28.79%(-24.3%)
Dec 2023
-35.92%(+55.4%)
-38.01%(-6.9%)
Sep 2023
-
-40.81%(+9.7%)
Jun 2023
-
-37.21%(-1.0%)
Mar 2023
-
-37.60%(-15.0%)
Dec 2022
-23.12%(-48.6%)
-44.22%(+1.6%)
Sep 2022
-
-43.52%(-3.6%)
Jun 2022
-
-45.15%(-0.3%)
Mar 2022
-
-45.30%(+6.8%)
Dec 2021
-44.94%
-
Dec 2021
-
-42.43%(-0.1%)
DateAnnualQuarterly
Sep 2021
-
-42.48%(-2.3%)
Jun 2021
-
-43.46%(-12.3%)
Mar 2021
-
-49.54%(-1.8%)
Dec 2020
-52.57%(-1.8%)
-50.43%(-4.1%)
Sep 2020
-
-52.59%(-1.3%)
Jun 2020
-
-53.30%(-3.5%)
Mar 2020
-
-55.24%(+9.6%)
Dec 2019
-53.53%(-8.8%)
-50.38%(+12.0%)
Sep 2019
-
-44.98%(+9.1%)
Jun 2019
-
-41.23%(-12.1%)
Mar 2019
-
-46.91%(+5.7%)
Dec 2018
-58.70%(-50.9%)
-44.39%(+15.4%)
Sep 2018
-
-38.45%(+28.9%)
Jun 2018
-
-29.82%(-64.2%)
Mar 2018
-
-83.29%
Dec 2017
-119.57%(+14.6%)
-
Dec 2016
-104.30%
-

FAQ

  • What is Dianthus Therapeutics, Inc. annual return on equity?
  • What is the all-time high annual ROE for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. annual ROE year-on-year change?
  • What is Dianthus Therapeutics, Inc. quarterly return on equity?
  • What is the all-time high quarterly ROE for Dianthus Therapeutics, Inc.?
  • What is Dianthus Therapeutics, Inc. quarterly ROE year-on-year change?

What is Dianthus Therapeutics, Inc. annual return on equity?

The current annual ROE of DNTH is -32.60%

What is the all-time high annual ROE for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high annual return on equity is -23.12%

What is Dianthus Therapeutics, Inc. annual ROE year-on-year change?

Over the past year, DNTH annual return on equity has changed by +3.32% (+9.24%)

What is Dianthus Therapeutics, Inc. quarterly return on equity?

The current quarterly ROE of DNTH is -34.15%

What is the all-time high quarterly ROE for Dianthus Therapeutics, Inc.?

Dianthus Therapeutics, Inc. all-time high quarterly return on equity is -23.69%

What is Dianthus Therapeutics, Inc. quarterly ROE year-on-year change?

Over the past year, DNTH quarterly return on equity has changed by -9.57% (-38.93%)
On this page